JPRN-UMIN000033180已完成未知
A trial evaluating the efficacy of paprika oleoresin intake on bone metabolism: A randomized, placebo-controlled, double-blind, parallel-group comparison trial. - A trial evaluating the efficacy of paprika oleoresin intake on bone metabolism
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
The percentage decrease of TRACP-5b at 24 weeks was significantly higher for paprika oleoresin than the placebo. There were no significant differences in sNTX or bone formation markers, although paprika oleoresin decreased each marker compared with the placebo.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •a) Subjects who are diagnosis with osteoporosis (Subjects who have less than 70% in total amount of bone mineral density for lumbar vertebra of YAM score). b) Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure or myocardial infarction. c) Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases. d) Subjects who take supplements, "Foods for Specified Health Uses," "Foods with Functional Claims," or "Foods with Nutrient Function Claims" related to bone metabolism such as calcium, vitamin D, vitamin K, magnesium, and isoflavones (including daidzein, genistein, equol, or etc.) more than once a week. e) Subjects who are currently taking medications (including herbal medicines) and supplements. f) Smoker g) Subjects who are allergic to medicines and/or the test food related products. h) Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial. i) Subjects who are judged as ineligible to participate in the study by the physician.
研究者
相似试验
已完成
4 期
Persantin Preceding Elective PCICoronary Heart DiseasePercutaneous Transluminal Coronary AngioplastyAtherosclerosisNCT00767663Radboud University Medical Center30
已完成
3 期
A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to AtorvastatinHyperlipidemiaNCT00195793Abbott174
已完成
不适用
Study to examine the efficacy of modified treat and extend regimen of aflibercept to branch retinal vein occlusion with cystoid macular edemabranch retinal vein occlusionJPRN-UMIN000024587Jichi Medical University50
已完成
3 期
Efficacy and Safety of Suvorexant (MK-4305) for Reducing Incidence of Delirium in Japanese Participants at High Risk of Delirium (MK-4305-085)DeliriumNCT04571944Merck Sharp & Dohme LLC207
招募中
不适用
Tauropace to Prevent Cardiac Implantable Device Infections in Heart Failure PatientsInfection CardiacCardiac Implantable Electronic Device InfectionsHigh RiskHeart FailureNCT05103267Federico II University500